IFP Advisors Inc Has $8.98 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

IFP Advisors Inc grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,138 shares of the healthcare conglomerate's stock after purchasing an additional 911 shares during the period. IFP Advisors Inc's holdings in UnitedHealth Group were worth $8,977,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new position in UnitedHealth Group in the 4th quarter worth $6,375,744,000. GAMMA Investing LLC increased its position in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares during the period. Northern Trust Corp increased its position in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the period. Finally, Capital International Investors grew its holdings in UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 1.0%

Shares of NYSE UNH traded up $2.89 on Wednesday, reaching $288.02. 5,281,146 shares of the company traded hands, compared to its average volume of 11,183,405. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a 50 day moving average of $304.47 and a 200 day moving average of $432.39. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $261.27 billion, a PE ratio of 12.06, a P/E/G ratio of 1.38 and a beta of 0.45.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Analyst Ratings Changes

Several research firms have weighed in on UNH. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research report on Friday, June 20th. Baird R W cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $394.43.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.